FR5153M - - Google Patents
Info
- Publication number
- FR5153M FR5153M FR38810A FR38810A FR5153M FR 5153 M FR5153 M FR 5153M FR 38810 A FR38810 A FR 38810A FR 38810 A FR38810 A FR 38810A FR 5153 M FR5153 M FR 5153M
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB47105/64A GB1114313A (en) | 1964-11-19 | 1964-11-19 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR5153M true FR5153M (fr) | 1967-06-12 |
Family
ID=10443741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR38810A Expired FR5153M (fr) | 1964-11-19 | 1965-11-17 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US3322625A (fr) |
| FR (1) | FR5153M (fr) |
| GB (1) | GB1114313A (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3482015A (en) * | 1965-02-08 | 1969-12-02 | Merck & Co Inc | Aerosol composition of phenylephrine tartrate and the production of such |
| US3891749A (en) * | 1969-10-07 | 1975-06-24 | Rech Pharm Scientifiques | Digestive pharmaceutical composition comprising S-carboxymethyl cysteine for reducing viscosity of respiratory tract secretions, and method of treating therewith |
| USRE29256E (en) | 1969-10-07 | 1977-06-07 | Recherche Pharmaceutiques Et Scientifiques | Digestive pharmaceutical composition comprising S-carboxymethyl cysteine for reducing viscosity of respiratory tract secretions, and method of treating therewith |
| AU460289B2 (en) * | 1971-03-16 | 1975-04-07 | Aerosol composition containing a vasoconstrictor | |
| US3857951A (en) * | 1973-09-14 | 1974-12-31 | Cassenne Lab Sa | Use of 2-mercaptopropionylglycine and its alkali metal salts in treating respiratory diseases |
| US4581225A (en) * | 1984-04-25 | 1986-04-08 | Eli Lilly And Company | Sustained release intranasal formulation and method of use thereof |
| US5340587A (en) * | 1985-05-22 | 1994-08-23 | Liposome Technology, Inc. | Liposome/bronchodilator method & System |
| US5192528A (en) * | 1985-05-22 | 1993-03-09 | Liposome Technology, Inc. | Corticosteroid inhalation treatment method |
| GB9018994D0 (en) * | 1990-08-31 | 1990-10-17 | Secr Defence | Toxic agent protective compounds |
| US5603918A (en) * | 1995-06-09 | 1997-02-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | Aerosol composition of a salt of ipratropium and a salt of albuterol |
| US20040265238A1 (en) * | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
| ES2363249T3 (es) * | 2005-05-31 | 2011-07-28 | Akzo Nobel N.V. | Disolución de acelerador estable durante el almacenamiento. |
| US8367734B1 (en) | 2005-08-11 | 2013-02-05 | Amphastar Pharmaceuticals Inc. | Stable epinephrine suspension formulation with high inhalation delivery efficiency |
| US20070286814A1 (en) * | 2006-06-12 | 2007-12-13 | Medispray Laboratories Pvt. Ltd. | Stable aerosol pharmaceutical formulations |
| US11517525B2 (en) * | 2015-09-18 | 2022-12-06 | Hikma Pharmaceuticals Usa Inc. | Epinephrine spray formulations |
| US11571384B2 (en) * | 2015-09-18 | 2023-02-07 | Hikma Pharmaceuticals Usa Inc. | Epinephrine spray formulations |
-
1964
- 1964-11-19 GB GB47105/64A patent/GB1114313A/en not_active Expired
-
1965
- 1965-11-15 US US507701A patent/US3322625A/en not_active Expired - Lifetime
- 1965-11-17 FR FR38810A patent/FR5153M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US3322625A (en) | 1967-05-30 |
| GB1114313A (en) | 1968-05-22 |